# KETOROLAC TROMETHAMINE
> **ANDA215745** · Abbreviated New Drug Application (Generic) · Sponsor: LEADING · Approved 2023-02-23
## Drug
- **FDA Application Number:** ANDA215745
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** KETOROLAC TROMETHAMINE
- **Generic name:** KETOROLAC TROMETHAMINE
- **Active ingredients:** KETOROLAC TROMETHAMINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LEADING
- **Manufacturer:** Leading Pharma, LLC
- **First approval:** 2023-02-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215745)
---
*MORVS · CC0 1.0*